Clinical Trial Update: Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating combination chemotherapy in patients with platinum-resistant recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: University of Southern California | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED